NEW YORK, Feb. 8, 2024 /PRNewswire/ -- Attention BioVie Inc. ("BioVie") (NASDAQ: BIVI) shareholders:

The Law Offices of Vincent Wong (PRNewsfoto/The Law Offices of Vincent Wong)

The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on behalf of investors who purchased between August 5, 2021 and November 29, 2023.

If you suffered a loss on your investment in BioVie, contact us about potential recovery by using the link below. There is no cost or obligation to you.

https://www.wongesq.com/pslra-1/biovie-class-action-submission-form/?prid=66252&wire=4

ABOUT THE ACTION: The class action against BioVie includes allegations that the Company made materially false and/or misleading statements and/or failed to disclose that: (1) BioVie was not conducting proper oversight of its Phase 3 clinical trial; (2) the COVID-19 pandemic significantly and negatively impacted the Company's ability to adequately conduct proper oversight of the Phase 3 clinical trial; (3) due to lack of proper oversight and reliance on contract research organizations, the data from defendants' Phase 3 clinical trial faced a greater risk of being unreliable and that the majority of patients would have to be excluded from the clinical trial; (4) as a result of the significant exclusions from the trial results, the Phase 3 clinical trial would fail to meet its primary endpoints; and (5) statements about BioVie's business, operations, prospects, and compliance with current good clinical practices were materially false and/or misleading and/or lacked a reasonable basis at all relevant times.

DEADLINE: March 19, 2024

Aggrieved BioVie investors only have until March 19, 2024 to request that the Court appoint you as lead plaintiff. You are not required to act as a lead plaintiff in order to share in any recovery.

Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
E-Mail: vw@wongesq.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-alert-the-law-offices-of-vincent-wong-remind-biovie-investors-of-a-lead-plaintiff-deadline-of-march-19-2024-302056630.html

SOURCE The Law Offices of Vincent Wong